New York Fashion Week is not the same without America’s Next Top Model radiant star Jael Strauss, who died so young from metastatic breast cancer she was only 34! MBC has no cure and each year 685,000 people die globally. #NYFW #NYFW26

We are seeing far too many women under 35 diagnosed with metastatic breast cancer,and the cost is devastating. Kristin Juszczyk, designer of Taylor Swift’s iconic NFL jacket, has shared the heartbreak of losing her mom to metastatic breast cancer,she was so young too. #SuperBowl

There is an urgent need to include ER+/HER2- metastatic breast cancer in Avacta’s clinical trials. MBC is one of the fastest-growing cancers, increasingly affecting women under 35 and it remains incurable. No patient should be left behind. MBC must be included now. #AVCT

Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Development Program of Novel Selective Estrogen Receptor Modulator SERM Represent Treatment Option for Patients w/ESR1-Mutations. $ATHA $LGND

In loving memory of Anne Wipf, a gifted artist who created enchanted worlds of dreams and wonder. Her fairytale art continues to sparkle with magic and play. Though metastatic breast cancer took Anne from us, her spirit lives on through her art forever enchanting, forever loved.

Unforgettable Patricia Janečková her beautiful Pie Jesu had angelic quality. At only 25, taken by metastatic breast cancer too soon, her voice was so unique, one of the best. Her music remains a celestial beauty, forever lifting our hearts toward heaven.

No one is too young for cancer. Metastatic breast cancer is rising in women under 35, aggressive, relentless, and still without a cure. Heartbreaking loss of Christina Zajicek, taken far too soon by MBC at just 32 years old, so young, beautiful, and gone, but never forgotten. 💔

“ErSO-TFPy belongs to a new class of compounds that specifically target ERα+ metastatic breast cancer cells. It works by disrupting ionic balance inside the tumor cells, triggering extreme stress and a rapid, necrotic death.”

In loving memory of Anne Wipf, a remarkable artist who created magical worlds of beauty and wonder. Her carousel with horses running wild continues to inspire imagination.We lost Anne to metastatic breast cancer,her spirit lives on through her art,which will forever enchant us.💔

“New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced Metastatic HER2-Positive Breast Cancer.” $ALXO

Isla Sneddon found a lump in her breast age 15, but by the time she finally got diagnosed she only had six months to live, her parents say if she'd been treated as an adult she'd have survived. Tragically she passed away from metastatic breast cancer at age 17. 💔

“Caris scientists uncovered clinically relevant mechanisms of resistance to trastuzumab deruxtecan (T-DXd) in metastatic breast cancer. This study explains why patient responses vary and reveals how resistance can evolve over time.” $CAI

“Vosilasarm, a first in class SARM, as a new treatment strategy for AR+/ ER+/HER-2- metastatic breast cancer. The study is continuing with evaluation of vosilasarm in combination w/ SoC therapies including oral SERD, mTOR inhibitor and CDK4/6 inhibitors.”

A Phase Ia/Ib Dose-Escalation and Expansion Study GDC-0587 as a Monotherapy and in Combination With Giredestrant in Pts with Metastatic ER-Positive, HER2-Negative Breast Cancer Who Have Previously Progressed During or After CDK4/6 Inhibitor Therapy. $RHHBY

Phase1b/2 open-label trial of 225Ac-DOTATATE (RYZ101) in pts w/estrogen receptor-positive ER+ human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer expressing somatostatin receptors (SSTRs) & progressed after ADC (TRACY-1). $BMY

“Report initial data for Phase 1/2 Duravelo-3 trial for zelenectide pevedotin in NECTIN4-amplified breast cancer at a scientific conference in the second half of 2026.” $BCYC

“ImmunityBio Announces Durable Complete Response of 15 Months with a Chemotherapy-Free CD19 CAR-NK Cell Therapy in Waldenstrom Lymphoma.” Please prioritize metastatic breast cancer. $IBRX

“ViroMissile Announces First-in-Human Phase I Trial of IDOV-Immune for Advanced Solid Tumors. Study examines the safety and early efficacy of an oncolytic virus via a single intravenous dose.” #JPM26

“Roche’s Giredestrant, a next-generation selective oestrogen receptor degrader (SERD), currently in Phase III for metastatic breast cancer. Giredestrant + everolimus is in the pre-registration stage with the FDA, filing is expected in 2026.” $RHHBY #JPM26

“Histologically confirmed, ER+, HER2-negative, locally advanced and unresectable or metastatic breast cancer not amenable to treatment with curative intent.” MBC has no cure. #JPM26 $BMY